GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » LiqTech International Inc (NAS:LIQT) » Definitions » Capex-to-Revenue

LiqTech International (LiqTech International) Capex-to-Revenue : 0.16 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is LiqTech International Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

LiqTech International's Capital Expenditure for the three months ended in Dec. 2023 was $-0.63 Mil. Its Revenue for the three months ended in Dec. 2023 was $3.93 Mil.

Hence, LiqTech International's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.16.


LiqTech International Capex-to-Revenue Historical Data

The historical data trend for LiqTech International's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LiqTech International Capex-to-Revenue Chart

LiqTech International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.17 0.06 0.11 0.16

LiqTech International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.02 0.04 0.39 0.16

Competitive Comparison of LiqTech International's Capex-to-Revenue

For the Pollution & Treatment Controls subindustry, LiqTech International's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LiqTech International's Capex-to-Revenue Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, LiqTech International's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where LiqTech International's Capex-to-Revenue falls into.



LiqTech International Capex-to-Revenue Calculation

LiqTech International's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.893) / 18.002
=0.16

LiqTech International's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.632) / 3.93
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LiqTech International  (NAS:LIQT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


LiqTech International Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of LiqTech International's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LiqTech International (LiqTech International) Business Description

Traded in Other Exchanges
N/A
Address
Industriparken 22C, Ballerup, DNK, DK 2750
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics. The company generates maximum revenue from Ceramics segment. Geographically, it derives a majority of its revenue from Europe.
Executives
Simon Seidelin Stadil officer: Chief Financial Officer INDUSTRIPARKEN 22C, BALLERUP G7 2750
Martin Kunz director INDUSTRIPARKEN 22C, BALLERUP G7 2750
Fei Chen director, officer: Chief Executive Officer STOLBERGSVEJ 23, HORSHOLM G7 2970
Richard A Meeusen director P O BOX 23099, MILWAUKEE WI 532230099
Peyton Boswell director 805 THIRD AVE., 20TH FLOOR, NEW YORK NY 10022
Mark Vernon director 200 SOUTH BISCAYNE BLVD, MIAMI FL 33131
Alexander J Buehler director C/O INSITUFORM TECHNOLOGIES, INC., 17988 EDISON AVENUE, CHESTERFIELD MO 63005
Laurence W Lytton 10 percent owner 467 CENTRAL PARK WEST, NY NY 10025
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Claus Toftegaard officer: Chief Financial Officer INDUSTRIPARKEN 22C, BALLERUP G7 2750
Peter Leifland director VALEVAGEN 21,5-18264, DJURSHOLM V7 00000
Joel Gay director 10264 NW 75TH TERRACE, DORAL FL 33178
Norman H Pessin other: See Explanation of Responses C/O LEVY, HARKINS & CO., INC., 366 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Sandra F Pessin other: See Explanation of Responses C/O NORMAN PESSIN, 366 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Brian L. Pessin other: See Explanation of Responses 310 EAST 75TH STREET, APT. 2A, NEW YORK NY 10021